James Leal - Sep 7, 2021 Form 4 Insider Report for TANDEM DIABETES CARE INC (TNDM)

Role
SVP, Operations
Signature
s/ David B. Berger, Attorney-in-Fact for James A. Leal
Stock symbol
TNDM
Transactions as of
Sep 7, 2021
Transactions value $
$148,964
Form type
4
Date filed
9/9/2021, 04:38 PM
Previous filing
Aug 31, 2021
Next filing
Sep 29, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TNDM Common Stock Options Exercise $294K +3.57K +95.28% $82.34 7.33K Sep 7, 2021 Direct F1
transaction TNDM Common Stock Sale -$440K -3.57K -48.79% $123.00 3.75K Sep 7, 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TNDM Stock Option Options Exercise $294K +3.57K +83.35% $82.34 7.86K Sep 7, 2021 Common Stock 3.57K $82.34 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock received upon exercise of a stock option award.
F2 The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2020.
F3 The options vested as to twenty-five (25%) of the underlying shares on 5/27/2021, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the terms of Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").
F4 The expiration date for these options is 10 years from the date of grant.